Jakob Vowinckel

Deep proteomics of 997 treatment-naïve colorectal cancers defines six subgroups, splitting chromosomally unstable tumors into three and revealing a rare adverse subgroup, with H&E slide benchmarks.

This paper develops an automated sample preparation platform for bottom-up proteomics, demonstrating improved reproducibility, throughput, and suitability for drug development.

This paper introduces a label-free quantitative proteomics platform using microLC and SWATH acquisition, achieving high throughput and precision in protein quantification.